Press release
Respiratory Inhalers Market Top Companies Study - GlaxoSmithKline, Novartis, Boehringer Ingelheim, Cipla, AstraZeneca.
Respiratory Inhalers Market
According to the latest research by Insight Analytics, the global Respiratory Inhalers market was valued at USD 33.6 Billion in 2024. It is expected to reach USD 59.7 Billion by the year 2034, with a CAGR of 6.0 % during a forecast period of 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1288
In recent years, the incidence of respiratory disorders has increased significantly, primarily due to factors such as tobacco use, industrial emissions, environmental pollution, and the emergence of novel pulmonary diseases. Respiratory inhalers have become essential therapeutic devices, facilitating the administration of medications directly to the lungs for the treatment of chronic respiratory conditions. The market currently comprises a broad spectrum of delivery systems, including dry powder inhalers (DPIs), metered-dose inhalers (MDIs), nebulizers, and soft mist inhalers.
A major driver of market growth is the steadily rising global prevalence of respiratory diseases, which has led to heightened demand for effective treatment options and technologically advanced inhalation therapies. Growing healthcare expenditures and increased awareness of respiratory health further contribute to market expansion. Additionally, escalating air pollution-driven by factors such as forest fires, vehicular emissions, and industrial activities-continues to exacerbate respiratory conditions, thereby increasing reliance on inhalation therapies.
The integration of advanced imaging techniques such as fluoroscopy in pain management, coupled with continuous technological advancements and proactive governmental initiatives aimed at raising public awareness and improving access to innovative treatments, is expected to create significant growth opportunities for the respiratory inhaler market. However, market expansion may be hindered by the high cost of inhaler devices, the prevalence of alternative treatment options such as oral medications, and a general lack of user awareness regarding proper inhaler usage and administration techniques. These challenges underscore the need for educational programs and cost-effective solutions to support wider adoption and optimize clinical outcomes.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
North America is anticipated to contribute to the Respiratory Inhalers market over the forecast years. The major driving factor in this area is the increased spending in the healthcare sector, and it has numerous chances for market expansion in this area. In this area, there is a greater awareness of non-prescription respiratory inhalers. Additionally, developing long-acting and novel respiratory inhalers will spur market expansion in this area. R&D and innovation are additional commercial drivers in this area. In addition, the Asia Pacific Respiratory Inhalers market is expected to grow significantly during the forecast period because there are more older people and more people are becoming aware of lung problems. The expanding healthcare infrastructure presents more chances for the market expansion of respiratory inhalers. The highest respiratory cases in this area are driving up demand for inhalers.
Major market players operating in the Respiratory Inhalers market include
GlaxoSmithKline, Novartis, Boehringer Ingelheim, Cipla, AstraZeneca, Propeller Health, Beximco Pharmaceuticals (Beximco Pharma), H&T Presspart, Cohero Health, CHIESI Farmaceutici, Mundipharma, 3M, HELTMAN Medikal, Adherium, Luckys Pharma, Amiko Digital Health, Teva Pharmaceutical Industries, Vectura Group, PULMOTREE MEDICAL GmbH, and Vapo Health.
Recent collaborations and agreements in the market:
• In October 2020, Zydus Cadila introduced the country's first pressurized metering dose inhalers for chronic obstructive pulmonary disease patients.
• In July 2020, ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder for Patients with Asthma and COPD was introduced by Teva Respiratory, LLC., a U.S. subsidiary of Teva Pharmaceutical Industries Ltd.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1288
Market Segments
Global Respiratory Inhalers Market, by Products, 2022-2030 (Value US$ Mn)
• Metered Dosage
• Dry Powder Inhaler
• Nebulizers
• Compressed Air Nebulizers
• Ultrasonic Nebulizers
• Mesh Nebulizers
Global Respiratory Inhalers Market, by Patient, 2022-2030 (Value US$ Mn)
• Adults
• Pediatric
Global Respiratory Inhalers Market, by Technology, 2022-2030 (Value US$ Mn)
• Manually Operated Inhaler Devices
• Digitally Operated Inhaler Devices
Global Respiratory Inhalers Market, by End-User, 2022-2030 (Value US$ Mn)
• Hospital Pharmacies
• Retail
• Online
Global Respiratory Inhalers Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Respiratory Inhalers Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Respiratory Inhalers Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Respiratory Inhalers Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Respiratory Inhalers Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Respiratory Inhalers Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Respiratory Inhalers market
To receive an industry overview and future trends in the Respiratory Inhalers market
To analyze the Respiratory Inhalers market drivers and challenges
To get information on the Respiratory Inhalers market value (US$Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Respiratory Inhalers market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-respiratory-inhalers-market/1288
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Respiratory Inhalers Market Top Companies Study - GlaxoSmithKline, Novartis, Boehringer Ingelheim, Cipla, AstraZeneca. here
News-ID: 4104104 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Rare Earth Magnet Market Size, Share and Trends Analysis Report 2025-2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rare Earth Magnet Market- (By Type (Neodymium-Iron-Boron Magnet (NdFeB), Samarium Cobalt Magnet (SmCo)), Product (Countersunk Magnets, Circular Disc Magnets, Hook & Eyebolt Magnets, Cylindrical Rod Magnets, Circular Ring Magnets, Rectangular, Self-Adhesive, Pot & Clamping Magnets), Application (Automotive Industry, Food & Drink Processing, Aerospace Industry, Renewable Energy, Consumer Electronics, Deep Sea Exploration, Others)), Trends, Industry Competition…
Partially Hydrolyzed Polyacrylamide (PHPA) Market Survey Detailed Analysis and F …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Partially Hydrolyzed Polyacrylamide (PHPA) Market- (By Type (Anionic, Cationic, Non-ionic, Others), By Function (Viscosifying Agent, Shale bore-hole Stabilizer, Excapsulator, Flocculation Agent, Others), By Application (Drilling Fluids, Water Treatment Additive, Soil Stabilization, Paper Manufacturing, Others), By End-Use (Oil & Gas, Waste Water Treatment, Mining, Agriculture, Paper, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
Modular Construction Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Modular Construction Market Size, Share & Trends Analysis Report By Type (permanent, relocatable), Module (Four-Sided Modules, Open-Sided Modules, Partially Open Sided Modules, Mixed Modules & Floor Cassettes, Modules Supported By a Primary Structure), Material (steel, wood, concrete), End-user (residential, office, education, retail & commercial, hospitality, healthcare), Region, Market Outlook And Industry Analysis 2034"
The global modular…
Metal Recycling Market Current Scenario with Future Trends Analysis to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Metal Recycling Market- (By Type (Ferrous, Non-Ferrous Metals), By Equipment (Shredders, Shears, Granulating Machines, Briquetting Machines), By End-User (Building and Construction, Packaging, Automotive, Shipbuilding, Electronics Equipment, Electrical Equipment)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Metal Recycling Market Size is valued at 549.4…
More Releases for Inhaler
Z!NGHA Introduces Dual-Chamber Aromatherapy Nasal Inhaler
Image: https://www.getnews.info/uploads/e696f4bdf98524eaf4f4f4bc89f2369f.jpg
Miami, FL - December 09, 2024 - Z!NGHA, a new player in the wellness space, is thrilled to announce the launch of its flagship product, the Z!NGHA Double Nasal Inhaler, an innovation that combines the therapeutic benefits of aromatherapy and essential oils with the on-the-go convenience of a dual-chamber nasal inhaler. Unlike the industry standard single chamber nasal inahlers, Z!ngha offers simultaneous inhalation through both nostrils, redefining aromatherapy for…
Asthma Inhaler Device Market By Type (Metered-dose inhaler, MDI with a spacer, D …
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. The research report on the market for asthma inhaler devices offers analysis and insights into the numerous aspects that are anticipated to be present over the course of the forecast period as well as…
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma…
Oxygen Inhaler Market Size, Share, Growth & Forecast 2026
Global Oxygen Inhaler Market report focuses on Oxygen Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents the overall Oxygen Inhaler market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for…
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the…
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…
